Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|April 4, 2022
Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary FibrosisSuh-Young Lee, Chang-Min Lee, Bing Ma, et al.
The Journal of Clinical Investigation|November 1, 2021
CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responsesBing Ma, Bedia Akosman, Suchitra Kamle, et al.
JCI Insight|April 28, 2026
Bispecific targeting of CHI3L1 and PD-1 as a therapeutic strategy for pulmonary fibrosisHan-Seok Jeong, Takayuki Sadanaga, Joyce H Lee, et al.
Immunotargets and Therapy|March 25, 2026
Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage DifferentiationTakayuki Sadanaga, Han-Seok Jeong, Roberto Cortez, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Kasugamycin inhibits melanoma lung metastasis and regulates CHI3L1-driven M2-like tumor-associated macrophage differentiationTakayuki Sadanaga, Han-Seok Jeong, Roberto Cortez, et al.
Oncotargets and Therapy|October 29, 2015
A human leucyl-tRNA synthetase as an anticancer targetGuangwei Gao, Ying Yao, Kun Li, et al.
Translational Oncology|August 23, 2024
Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancerSuchitra Kamle, Bing Ma, Gail Schor, et al.
Pageof 4